Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
-
Narrated by:
-
By:
About this listen
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
- Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
What listeners say about Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.